title: Neonatal mythbusters: evaluating the evidence for and against pharmacologic and nonpharmacologic management of gastroesophageal reflux.
abstract: Gastroesophageal reflux (GER) is a challenging clinical entity that has often been associated with a number of negative clinical outcomes. The treatment of this condition lacks evidence and is often based on anecdotal beliefs and myths. This article will define GER and review the recommendations for the diagnosis of GER as well as review the evidence for both pharmacologic and nonpharmacologic treatment of GER.
authors: Sunnybrook Health Sciences Centre, 2075 Bayview Ave.Toronto, Ontario, Canada M4N 3M5. patti.schurr@sunnybrook.ca
authors: Patti
authors: P
authors: Schurr
authors: Carla K
authors: CK
authors: Findlater
mesh_terms: D001418:Baclofen / Q000627:therapeutic use; D004750:Enteral Nutrition / Q000379:methods; D058786:GABA-B Receptor Agonists / Q000627:therapeutic use; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D041943:Infant Formula; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D016269:Milk Hypersensitivity / Q000150:complications; D056888:Patient Positioning; D054328:Proton Pump Inhibitors / Q000627:therapeutic use
chemical_list: D058786:GABA-B Receptor Agonists; D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D001418:Baclofen